By Deena Beasley (Reuters) – Gilead Sciences Inc on Thursday posted a higher-than-expected third-quarter profit on the back of strong…
McKinsey reaches deal with U.S. local governments over opioids
By Brendan Pierson (Reuters) -Leading consulting firm McKinsey & Co has agreed to settle claims by hundreds of U.S. local…
Merck lifts full-year forecast as Keytruda sales soar
By Michael Erman and Leroy Leo (Reuters) -Merck & Co on Thursday reported higher-than-expected third-quarter sales and profit on a…
China sees growing risk of weakening external demand in Q4
BEIJING (Reuters) – China’s economy is facing growing risks of slowing external demand in the fourth quarter, a commerce ministry…
Merck’s CEO to succeed Ken Frazier as chairman
(Reuters) – Merck & Co said on Wednesday Chief Executive Officer Rob Davis would succeed Chairman Ken Frazier, taking on…
JPMorgan M&A co-head urges potential buyers to be proactive, sees more health deals
By Abigail Summerville NEW YORK (Reuters) – Companies that are considering acquisitions should use a slowdown in deals to scope…
The bear market blues: a diagnosis for our times
By Alden Bentley (Reuters) – War. Inflation. Polarization. Appalling headlines ricochet around the internet, stocks are skidding, wealth is eroding…
Australia’s Medibank says data of 4 million customers accessed by hacker
By Shashwat Awasthi and Lewis Jackson (Reuters) -Medibank Private Ltd, Australia’s biggest health insurer, said on Wednesday a cyber hack…
Bristol Myers Q3 sales fall on Revlimid, forex pressure
(Reuters) – Drugmaker Bristol Myers Squibb said on Tuesday its third-quarter sales fell from last year as generic competition ate…
Fresenius CEO signals realignment, confirms call with Elliott – FAZ newspaper
FRANKFURT (Reuters) – Newly appointed Fresenius CEO Michael Sen said that the company’s debt-financed growth strategy cannot continue, in an…